At a glance
- Originator AstraZeneca
- Class Antihypertensives; Neuroprotectants; Nootropics; Vasodilators
- Mechanism of Action Adenosine A2 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Angina pectoris; Cognition disorders; Neurological disorders
Most Recent Events
- 06 Sep 2000 Discontinued-Preclinical for Angina pectoris in United Kingdom (Unknown route)
- 06 Sep 2000 Discontinued-Preclinical for Cognition disorders in United Kingdom (Unknown route)
- 06 Sep 2000 Discontinued-Preclinical for Neurological disorders in United Kingdom (Unknown route)